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LETTER TO THE EDITOR
Peripherally inserted central catheters (PICC) use in patients with chronic kidney
disease (CKD)
Sonia Yaqub, Muhammad Raheel Abdul Razzaque
Madam, the use of peripherally inserted central catheters
(PICC) has expanded rapidly in recent years. PICCs are
perceived to be a safe and effective form of venous access
with certain advantages over others such as ease of
placement, lower rate of complications compared to nontunnelled central venous catheters, and longevity
allowing home administration of drugs. However, a large
number of complications associated with PICCs are being
recognized increasingly such as thromboembolism and
trauma to the vessels eventually causing central venous
stenosis. This can have very significant implications for
patients suffering from chronic kidney disease (CKD) who
are at risk for progression to kidney failure and eventually
require haemodialysis (HD).1 It is of paramount
importance to maintain integrity of veins to provide a
future haemodialysis vascular access for these patients.
PICC lines may cause local trauma to vessels and hence
may preclude future vascular access creation and its
longevity. Due to multiple comorbid conditions, patients
with CKD are more likely to have PICCs potentially
increasing their risk for loss of veins.2 A strong and
independent association between PICC use and lack of a
functioning arterio-venous fistula has been proven in a
case-control study of HD patients.3 Guidelines have been
developed by various societies to prevent future access
failure in CKD patients. The American Society of
Nephrology, National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (KDOQI) and the Fistula First
Breakthrough Initiative (FFBI) recommend against PICC
use in patients at risk for or with known stage 3, stage 4 or
5 CKD without consulting a nephrologist.4-6
It is essential to understand that vein protection must
begin long before initiation of HD is needed. It cannot be
over emphasized that the potential long-term
consequences of the PICCs must be weighed against their
short-term convenience in CKD patients. The ultimate

responsibility lies with nephrology community to educate
non-nephrologist clinicians about the need to have vein
protection strategies aimed at preserving future HD
access. Moreover, given the fact that PICC insertion occurs
most commonly in the hospital setting, there is a pressing
need to apprise the practitioners/clinicians of careful
selection of patients. Furthermore, there is a need for the
interventionists who place the lines to be aware of and to
adhere to afore mentioned guidelines. At institutional
level, policies and protocols that require nephrology
consultation for any PICC request in patients with CKD
may be considered and implemented. This may require a
collaborative approach among physicians from various
specialties and could be facilitated with electronic alerts
in hospitals where electronic health records are in use.
Last but not the least, awareness needs to be created
among patients suffering from CKD and their family
members about the potential risks and avoidance of
PICCs.
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